Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value
NextTrip, Inc. (NTRP)
NASDAQ:AMEX Investor Relations:
neurotropebioscience.com/welcome_to_neurotrope_bioscience/investorsrelations.html
Company Research
Source: PR Newswire
NEW YORK, Oct. 8, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, today announced its plans to explore strategic alternatives to maximize shareholder value. "Following the results from our Phase 2 study of Bryostatin-1 in Alzheimer's disease, we believe a review of strategic alternatives is an important step toward preserving and enhancing shareholder value," stated Dr. Charles S. Ryan, Neurotrope's Chief Executive Officer. "The Board of Directors has formed a strategic alternatives committee to aid in evaluating the Company's alternatives, and we look forward to providing an update when appropriate."There can be no assurance that the formal strategic review of alternatives will result in any successful transaction or other outcome. The Company does not intend to comment further or publicly discuss the potential of alternate developments unless and until its Board of Directors h
Show less
Read more
Impact Snapshot
Event Time:
NTRP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRP alerts
High impacting NextTrip, Inc. news events
Weekly update
A roundup of the hottest topics
NTRP
News
- NextTrip Signs Agreement with J. Bradley Hilton's Hilton Advisory Group to Accelerate Premium Wellness Travel Products Across JOURNY.tv and Five Star Alliance [Yahoo! Finance Canada]Yahoo! Finance Canada
- NextTrip (NTRP) is now covered by Ascendiant Capital Markets. They set a "buy" rating and a $7.00 price target on the stock.MarketBeat
- NextTrip's JOURNY to Launch New Wedding Series "I DO: In Destination" Hosted by Former Bachelor Star, Podcaster and Celebrity Ben Higgins [Yahoo! Finance Canada]Yahoo! Finance Canada
- NextTrip Updates Shareholders on KC Global Media Joint Venture, JOURNY International Expansion, and GoUSA Channel Integration [Yahoo! Finance Canada]Yahoo! Finance Canada
- Vanderbilt Report: NextTrip's 'Watch It, Book It' Model Gains Momentum as Revenue Surges and Company Acquires 200M-Viewer Travel Platform [Yahoo! Finance Canada]Yahoo! Finance Canada
NTRP
Sec Filings
- 3/6/26 - Form 8-K
- 2/23/26 - Form RW
- 2/19/26 - Form 8-K
- NTRP's page on the SEC website